Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Ruocco

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
Skinmed|March 9, 2006
A possible mechanism for phenol-induced pemphigusSarah Brenner, Vincenzo Ruocco, Eleonora Ruocco, et al.
Clinics in Dermatology|June 29, 2013
Contact dermatitis: facts and controversiesRonni Wolf, Edith Orion, Eleonora Ruocco, et al.
Clinics in Dermatology|June 29, 2013
Patch testing: facts and controversiesRonni Wolf, Edith Orion, Vincenzo Ruocco, et al.
Dermatology (Basel, Switzerland)|September 7, 2011
Kaposi's sarcoma restricted to an immunocompromised districtVincenzo Ruocco, Marcella Brasiello, Gyozo Szolnoky, et al.
Skinmed|November 12, 2005
Targeting the "target lesions"Ronni Wolf, Hagit Matz, Edith Orion, et al.
Journal of the American Academy of Dermatology|January 5, 2002
Isotopic response after herpesvirus infection: an updateVincenzo Ruocco, Eleonora Ruocco, Ilaria Ghersetich, et al.
Clinics in Dermatology|December 20, 2002
Adverse drug reactions and graft-versus-host reaction: unapproved treatmentsVincenzo Ruocco, Guido Sacerdoti, Pietro Farro, et al.
Clinics in Dermatology|June 29, 2013
Phacomatosis pigmento-pigmentaria: should we add a new type of phacomatosis? Fact and controversiesRonni Wolf, Danny Wolf, Vincenzo Ruocco, et al.
Clinics in Dermatology|August 23, 2011
Opportunistic localization of skin lesions on vulnerable areasVincenzo Ruocco, Eleonora Ruocco, Giampiero Brunetti, et al.
Clinics in Dermatology|June 15, 2010
Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversiesAda Lo Schiavo, Rosa Valentina Puca, Vincenzo Ruocco, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Skinmed|March 9, 2006
A possible mechanism for phenol-induced pemphigusSarah Brenner, Vincenzo Ruocco, Eleonora Ruocco, et al.
Clinics in Dermatology|June 29, 2013
Contact dermatitis: facts and controversiesRonni Wolf, Edith Orion, Eleonora Ruocco, et al.
Clinics in Dermatology|June 29, 2013
Patch testing: facts and controversiesRonni Wolf, Edith Orion, Vincenzo Ruocco, et al.
Dermatology (Basel, Switzerland)|September 7, 2011
Kaposi's sarcoma restricted to an immunocompromised districtVincenzo Ruocco, Marcella Brasiello, Gyozo Szolnoky, et al.
Skinmed|November 12, 2005
Targeting the "target lesions"Ronni Wolf, Hagit Matz, Edith Orion, et al.
Journal of the American Academy of Dermatology|January 5, 2002
Isotopic response after herpesvirus infection: an updateVincenzo Ruocco, Eleonora Ruocco, Ilaria Ghersetich, et al.
Clinics in Dermatology|December 20, 2002
Adverse drug reactions and graft-versus-host reaction: unapproved treatmentsVincenzo Ruocco, Guido Sacerdoti, Pietro Farro, et al.
Clinics in Dermatology|June 29, 2013
Phacomatosis pigmento-pigmentaria: should we add a new type of phacomatosis? Fact and controversiesRonni Wolf, Danny Wolf, Vincenzo Ruocco, et al.
Clinics in Dermatology|August 23, 2011
Opportunistic localization of skin lesions on vulnerable areasVincenzo Ruocco, Eleonora Ruocco, Giampiero Brunetti, et al.
Clinics in Dermatology|June 15, 2010
Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversiesAda Lo Schiavo, Rosa Valentina Puca, Vincenzo Ruocco, et al.
Pageof 12